methylformamide has been researched along with Colonic Neoplasms in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (75.86) | 18.7374 |
| 1990's | 6 (20.69) | 18.2507 |
| 2000's | 1 (3.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boga, C; Calonghi, N; Masotti, L; Pagnotta, E | 1 |
| Cordeiro, RF; Savarese, TM | 2 |
| Bliven, SF; Dexter, DL; Glicksman, AS; Lee, ES; Leith, JT | 1 |
| Calabresi, P; Dexter, DL; Diamond, I; Matook, GM; Spremulli, EN | 1 |
| Bucci, B; D'Agnano, I; Del Bufalo, D; Zupi, G | 1 |
| Chatterjee, D; Savarese, TM | 1 |
| D'Agnano, I; Leonetti, C; Nuti, M; Turchi, V; Zupi, G | 1 |
| Candiloro, A; Cucco, C; D'Agnano, I; Marangolo, M; Zupi, G | 1 |
| Arancia, G; Formisano, G; Greco, C; Leonetti, C; Malorni, W; Marangolo, M; Zupi, G | 1 |
| D'Incalci, M; Erba, E; Laudonio, N; Leonetti, C; Zupi, G | 1 |
| Glicksman, AS; Lee, ES; Leite, DV; Leith, JT | 1 |
| Allalouf, D; Friedman, J; Levinsky, H; Seger, M | 1 |
| Chatterjee, D; Mendelsohn, A; Savarese, TM; Shank, PR | 1 |
| Bill, CA; Tofilon, PJ; Vines, CM | 1 |
| Arundel, CM; Tofilon, PJ; Vines, CM | 1 |
| Arancia, G; Formisano, G; Greco, C; Iosi, F; Laudonio, N; Malorni, W; Marangolo, M; Zupi, G | 1 |
| Leith, JT | 1 |
| Bliven, SF; Leith, JT | 1 |
| Clausen, K; Martin, EW; McCabe, DP; O'Dwyer, PJ; Sickle-Santanello, BJ; Woltering, EA | 1 |
| Cheng, E; Geller, N; Hollander, P; Kemeny, N; Tauer, K | 1 |
| Abrams, J; Eisenberger, M; Kaplan, RS; Tchekmedyian, NS; Van Echo, D | 1 |
| Arundel, CM; Tofilon, PJ | 1 |
| Klijn, JG; Planting, AS; Stoter, G; Verweij, J | 1 |
| Eisenhauer, EA; Kerr, I; Quirt, I; Weinerman, BH | 1 |
| Bliven, SF; Calabresi, P; Ferrari, LA; Glicksman, AS; Leith, JT; Wiemann, M | 1 |
| Arundel, CM; Glicksman, AS; Lee, ES; Leite, DV; Leith, JT | 1 |
| Dexter, DL; Dibner, MD; Ireland, KA; Koerner, LA | 1 |
| Dexter, DL; Glicksman, AS; Lee, ES; Leith, JT; Vayer, AJ | 1 |
1 trial(s) available for methylformamide and Colonic Neoplasms
| Article | Year |
|---|---|
Phase II trial of N-methylformamide in patients with advanced colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Colonic Neoplasms; Drug Evaluation; Female; Formamides; Humans; Male; Middle Aged; Rectal Neoplasms; Sepsis | 1986 |
28 other study(ies) available for methylformamide and Colonic Neoplasms
| Article | Year |
|---|---|
N-methylformamide and 9-hydroxystearic acid: two anti-proliferative and differentiating agents with different modes of action in colon cancer cells.
Topics: Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cytoskeleton; Formamides; Humans; Microscopy, Confocal; Stearic Acids | 2006 |
Reversal by L-cysteine of the growth inhibitory and glutathione-depleting effects of N-methylformamide and N,N-dimethylformamide.
Topics: Antineoplastic Agents; Cell Division; Cell Line; Cell Survival; Clone Cells; Colonic Neoplasms; Cysteine; Dimethylformamide; Drug Antagonism; Formamides; Glutathione; Humans | 1984 |
Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Survival; Colonic Neoplasms; Combined Modality Therapy; Formamides; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 1984 |
Inhibition of the growth of human colon cancer xenografts by polar solvents.
Topics: Animals; Cell Division; Cell Line; Colonic Neoplasms; Dimethylformamide; Female; Formamides; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Solvents; Transplantation, Heterologous | 1982 |
N-methylformamide as a potential therapeutic approach in colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Synergism; Flow Cytometry; Formamides; Humans; Integrins; Tumor Cells, Cultured | 1994 |
Posttranscriptional regulation of c-myc proto-oncogene expression and growth inhibition by recombinant human interferon-beta ser17 in a human colon carcinoma cell line.
Topics: 2',5'-Oligoadenylate Synthetase; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Formamides; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Proto-Oncogene Mas; Recombinant Proteins; Ribonucleases; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1992 |
N-methylformamide effects on cell proliferation and antigenic pattern in HT-29 colon carcinoma cell line.
Topics: Animals; Antigens, Neoplasm; Cell Division; Colonic Neoplasms; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Formamides; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1992 |
Importance of cell cycle perturbations on the effectiveness of N-methylformamide and anti-neoplastic drugs in combination.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Survival; Cisplatin; Colonic Neoplasms; Doxorubicin; Flow Cytometry; Formamides; Humans; Melanoma, Experimental; Tumor Cells, Cultured | 1991 |
Different effects of sequential combinations of N-methylformamide with 5-fluorouracil on human colon carcinoma cells growing in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Colonic Neoplasms; Drug Administration Schedule; Drug Synergism; Fluorouracil; Formamides; Humans; Male; Mice; Mice, Nude; Tumor Cells, Cultured | 1991 |
Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Colonic Neoplasms; DNA Damage; DNA, Neoplasm; Drug Synergism; Fluorouracil; Formamides; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1990 |
Enhanced X ray sensitivity of human colon tumor cells by combination of N-methylformamide with chemotherapeutic agents.
Topics: Antineoplastic Agents; Bleomycin; Cell Survival; Colonic Neoplasms; Drug Synergism; Fluorouracil; Formamides; Humans; In Vitro Techniques | 1986 |
Modulation of carcinoembryonic antigen release by HT-29 colon carcinoma line in the presence of different agents.
Topics: Acetamides; Azacitidine; Butyrates; Butyric Acid; Carcinoembryonic Antigen; Cell Differentiation; Colonic Neoplasms; Drug Synergism; Formamides; Humans; Tetradecanoylphorbol Acetate; Tretinoin | 1987 |
Reversible suppression of c-myc expression in a human colon carcinoma line by the anticancer agent N-methylformamide.
Topics: Antineoplastic Agents; Cell Division; Cell Line; Colonic Neoplasms; Formamides; Humans; Kinetics; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc; Proto-Oncogenes; RNA, Messenger; Suppression, Genetic; Transcription, Genetic | 1989 |
Enhancement of radiation-induced DNA double-strand breaks and micronuclei in human colon carcinoma cells by N-methylformamide.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; DNA; DNA Damage; DNA, Neoplasm; Formamides; Humans; In Vitro Techniques; Liver Neoplasms, Experimental; Mice; Micronucleus Tests; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1989 |
Chromatin modifications associated with N-methylformamide-induced radiosensitization of clone A cells.
Topics: Adenocarcinoma; Cell Differentiation; Chromatin; Clone Cells; Colonic Neoplasms; Formamides; Humans; Radiation-Sensitizing Agents | 1988 |
Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Colonic Neoplasms; Cytoskeleton; Fluorouracil; Formamides; Humans; Tumor Cells, Cultured | 1988 |
Modification of the hypoxic fraction of a xenografted human colon tumor by differentiation-inducing agents.
Topics: Animals; Butyrates; Butyric Acid; Cell Differentiation; Cell Survival; Colonic Neoplasms; Female; Formamides; Humans; Male; Mice; Neoplasm Transplantation; Oxygen; Transplantation, Heterologous | 1988 |
X ray responses of a human colon tumor cell line after exposure to the differentiation-inducing agent N-methylformamide: concentration dependence and reversibility characteristics.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Colonic Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Formamides; Humans; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1988 |
Use of polar solvents in chemoprevention of 1,2-dimethylhydrazine-induced colon cancer.
Topics: 1,2-Dimethylhydrazine; Animals; Body Weight; Colonic Neoplasms; Dimethyl Sulfoxide; Dimethylhydrazines; Formamides; Gastrointestinal Neoplasms; Male; Methylhydrazines; Rats; Rats, Inbred Strains; Solvents; Sulfones; Time Factors | 1988 |
Phase II study of N-methylformamide in patients with advanced colorectal cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Female; Formamides; Humans; Male; Middle Aged; Rectal Neoplasms | 1987 |
Enhancement of radiation-induced DNA-protein crosslinking by N-methylformamide.
Topics: Adenocarcinoma; Animals; Cell Line; Colonic Neoplasms; Cross-Linking Reagents; DNA; DNA Damage; DNA, Neoplasm; Formamides; Gamma Rays; Glutathione; Humans; Liver Neoplasms, Experimental; Mice; Proteins; Radiation Tolerance | 1987 |
Phase II study on oral N-methylformamide in metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Carcinoma; Colonic Neoplasms; Drug Evaluation; Female; Formamides; Humans; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms | 1987 |
Toxicity of oral N-methylformamide in three phase II trials: a report from the National Cancer Institute of Canada Clinical Trials Group.
Topics: Alkaline Phosphatase; Antineoplastic Agents; Aspartate Aminotransferases; Bilirubin; Canada; Chemical and Drug Induced Liver Injury; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Formamides; Glioma; Humans; Male; Melanoma; Nausea; Rectal Neoplasms | 1986 |
Induction of doxorubicin resistance in heterogeneous human colon tumor cells by N-methylformamide.
Topics: Adenocarcinoma; Cell Differentiation; Cell Survival; Clone Cells; Colonic Neoplasms; Doxorubicin; Drug Resistance; Formamides; Humans; Mutation | 1986 |
Potentiation of in vitro cytotoxic effects of misonidazole on human colon tumor cells by the differentiation-inducing agent N-methylformamide.
Topics: Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Drug Synergism; Formamides; Humans; In Vitro Techniques; Misonidazole | 1986 |
Role of glutathione depletion in the mechanism of action of N-methylformamide and N,N-dimethylformamide in a cultured human colon carcinoma cell line.
Topics: Buthionine Sulfoximine; Cell Cycle; Cell Line; Cisplatin; Colonic Neoplasms; Cysteine; Dimethylformamide; Dose-Response Relationship, Drug; Formamides; Glutathione; Humans; Methionine Sulfoximine; Solvents | 1986 |
Polar solvent-induced changes in membrane lipid lateral diffusion in human colon cancer cells.
Topics: Butyrates; Butyric Acid; Cell Line; Colonic Neoplasms; Diffusion; Dimethyl Sulfoxide; Dimethylformamide; Formamides; Humans; Membrane Fluidity; Membrane Lipids | 1985 |
Enhancement of the responses of human colon adenocarcinoma cells to X-irradiation and cis-platinum by N-methylformamide (NMF).
Topics: Adenocarcinoma; Cell Survival; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Drug Synergism; Formamides; Humans; In Vitro Techniques; Time Factors; X-Rays | 1985 |